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Introduction: Cardiotocography (CTG) is currently the most commonly used method 
for intrapartum fetal monitoring during labor. However, a high false-positive rate of 
fetal acidosis indicated by CTG leads to an increase in obstetric interventions. We de-
veloped a microdialysis probe that is integrated into a fetal scalp electrode allowing 
continuous measurement of lactate subcutaneously, thus giving instant information 
about the oxygenation status of the fetus. Our aim was to establish proof of concept 
in an animal model using a microdialysis probe to monitor lactate subcutaneously.
Material and methods: We performed an in vivo study in adult male wild-type Wistar 
rats. We modified electrodes used for CTG monitoring in human fetuses to incor-
porate a microdialysis membrane. Optimum flow rates for microdialysis were deter-
mined in vitro. For the in vivo experiment, a microdialysis probe was inserted into the 
skin on the back of the animal. De-oxygenation and acidosis were induced by lower-
ing the inspiratory oxygen pressure. Oxygenation and heart rate were monitored. A 
jugular vein cannula was inserted to draw blood samples for analysis of lactate, pH, 
pco2, and saturation. Lactate levels in dialysate were compared with plasma lactate 
levels.
Results: Baseline blood lactate levels were around 1 mmol/L. Upon de-oxygenation, 
oxygen saturation fell to below 40% for 1 h and blood lactate levels increased 2.5-
fold. Correlation of dialysate lactate levels with plasma lactate levels was 0.89 result-
ing in an R2 of .78 in the corresponding linear regression.
Conclusions: In this animal model, lactate levels in subcutaneous fluid collected by 
microdialysis closely reflected blood lactate levels upon transient de-oxygenation, 
indicating that our device is suitable for subcutaneous measurement of lactate. 
Microdialysis probe technology allows the measurement of multiple compounds in 
the dialysate, such as glucose, albumin, or inflammatory mediators, so this technique 
may offer the unique possibility to shed light on fetal physiology during the intrapar-
tum period.
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1  | INTRODUC TION
During labor, the well-being of the fetus is monitored to identify 
those fetuses that may become hypoxic and might benefit from in-
terventions such as cesarean section or instrumental delivery. When 
perinatal hypoxia persists, it may result in perinatal asphyxia, a major 
cause of neonatal death and morbidity.1,2
Cardiotocography (CTG) is currently the most commonly used 
method for continuous fetal monitoring during labor. However, there is 
no good evidence that supports the benefits of this method. Also, use 
of CTG during labor is associated with a significant increase in cesarean 
sections. Other disadvantages include subjectivity in the interpreta-
tion of the results and decreased mobility for the woman during labor.3
Fetal scalp blood sampling for pH or lactate analysis is used in ad-
dition to CTG and may reduce the risk of cesarean section compared 
with CTG alone.4 Although this method is referred to as the refer-
ence standard for investigation of fetal acidosis in labor, it has not 
been shown to result in significantly lower cesarean section rates or 
to improve fetal outcome.5-7
Other alternatives have been suggested. These include ST-
segment analysis of the fetal electrocardiography, fetal pulse ox-
imetry, and near-infrared spectroscopy.3,8 However, a convincing 
significant benefit over CTG has not been shown for any of these 
methods.9-11 Therefore, a method for intrapartum fetal monitoring 
that more accurately discriminates between absence and presence 
of hypoxia should be developed.
During prolonged hypoxia, anaerobic glycolysis as energy source 
causes metabolic acidosis and lactate accumulation in peripheral 
blood; a high blood lactate concentration at birth is a predictor of 
poor outcome in children.11 To measure fetal lactate, blood sampling 
from the fetal scalp can be performed during labor as a single or re-
peated procedure.12 There is evidence suggesting that measurement 
of lactate is more feasible than of pH.13,14
We developed a microdialysis probe integrated into a fetal scalp 
CTG electrode allowing continuous measurement of lactate and giv-
ing instant information about the oxygenation status of the fetus 
(European Patent No. 15726201.5, 2015).15
The aim of this study was to establish proof of concept by in-
vestigating whether our microdialysis probe can be used to monitor 
lactate subcutaneously in vivo in the hypoxic rat.
2  | MATERIAL AND METHODS
2.1 | Description of the device
We modified electrodes used for CTG monitoring in human fe-
tuses to incorporate a microdialysis membrane. A hypodermic 
needle (25G×5/8, B. Braun) was modified to accommodate a mi-
crodialysis membrane (regenerated cellulose, L = 3.0 mm, pores: 
18 kDa). The end of the microdialysis membrane was glued shut 
(Pattex). Sterile saline or phosphate-buffered saline was in-
fused along the membrane via fused silica tubings (Polymicro, 
TSP040105) and returned to the outlet via another fused silica 
membrane. The microdialysis probe was connected to a sterile sy-
ringe filled with sterile saline or phosphate-buffered saline using 
PEEK tubing (internal diameter 127 µm, outer diameter 508 µm; 
Western Analytical).
Figure 1A shows the position of the needle at the tip of the CTG 
electrode, which has a coiled electrode wire to attach it to the skin 
by turning it with gentle pressure. The microdialysis needle is po-
sitioned in such a way that the point of the needle does not ex-
tend beyond the coiled electrode, preventing damage to the deeper 
structures by the needle. Upon insertion of the CTG electrode in 
the scalp, the needle pierces the scalp, enabling sampling of the ex-
tracellular fluid.
Figure 1B shows the principle of the dialysis setup. Briefly, dial-
ysate fluid enters the dialysis setup through fused silica tubing and 
returns via the membrane to the outlet. Exchange of small molecules 
will occur between dialysis fluid and the subcutaneous fluid in the 
skin through an open surface of 3 mm when dialysis fluid runs along 
the microdialysis membrane. After passing the dialysis membrane, 
fluid can be collected for analysis of lactate.
2.2 | In vitro experiments
Before the in vivo experiments, the microdialysis setup was tested 
in vitro to determine optimum flow rates with respect to recovery of 
lactate. For this purpose, the device was attached to a syringe pump 
(CMA 102; CMA Microdialysis AB) and perfused with saline at flow 
rates of 1.5 µL/min (n = 4) and 5 µL/min (n = 2). The dialysis device 
was then suspended in a 50-mL beaker containing stirred lactate so-
lutions with a concentration of 10 mmol/L. The observed relative 
recoveries of lactate at flow rates of 1.5 and 5 µL/min were 24.7% 
K E Y W O R D S
cardiotocography, cesarean, delivery, fetal acidosis, fetal monitoring, fetal scalp electrode, 
lactate, prenatal care
Key message
In a rat model, lactate levels in subcutaneous fluid col-
lected by microdialysis closely reflected blood lactate lev-
els upon transient oxygen deprivation. This method could 
potentially be used as a tool for intrapartum human fetal 
monitoring.
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(±2.3) and 8.9% (±0.6), respectively, and the lowest flow rate was 
chosen for the in vivo experiments.
2.3 | In vivo experiments
Three adult male wild-type Wistar rats, each weighing approxi-
mately 500 g, were used for the experiments. The animals were 
ventilated through a breathing mask to regulate the supply of ox-
ygen and nitrogen (baseline: oxygen 0.8 L/min, nitrogen 0 L/min) 
and were anesthetized using isoflurane. After shaving, the micro-
dialysis probe was inserted in the skin of the back of the animal 
and fixed in place with a suture. A pulse oximeter was clamped 
to the tail of the animal to monitor oxygenation and heart rate. 
A jugular vein cannula was inserted to draw blood samples of 
100 µL each, every 10 min, for analysis of lactate, pH, pCO2, and 
saturation.
After stabilization for 15 min, dialysis sampling was started and 
acidosis was induced by simultaneously increasing nitrogen flow 
(0.8 L/min) and decreasing oxygen flow (0.05 L/min). De-oxygenation 
lasted for 60 min, after which restoration of saturation was induced 
using 0.8 L/min oxygen. Lactate and saturation were monitored for a 
further 20 min while saturation was restored.
Dialysis was performed using sterile saline solution at 1.5 µL/
min. Samples were collected in 300-µL polypropylene vials, for lac-
tate analysis. Lactate, pH, pCO2, and saturation in blood samples 
were analyzed using a handheld Abbott analyzer (Abbott analyzer; 
Abbott Diagnostics). Lactate from dialysis samples was quantified 
with an enzymatic assay in a 96-well plate (reagents from CMA 
Microdialysis AB).
2.4 | Ethical approval
All experiments were in accordance with Dutch law and were 




3.1.1 | Peripheral lactate, oxygenation, 
pH, and pCO2
Figure 2 shows the course of oxygen saturation and lactate over 
time. Upon de-oxygenation (t = 0 minute), saturation fell to below 
40% for 1 h. Baseline blood lactate levels were around 1 mmol/L. 
Blood lactate levels increased 2.5-fold upon de-oxygenation, start-
ing within 10 min after initiation of de-oxygenation. Upon restora-
tion of oxygenation, lactate levels returned to baseline levels rapidly.
Blood pH slowly decreased over the course of the experiment, 
and did not return to baseline within 20 min after oxygenation was 
restored. Similarly, pCO2 slowly increased, starting after 40 min of 
de-oxygenation, and kept rising upon re-oxygenation (Figure 3).
3.1.2 | Skin microdialysis of lactate
Figure 4 depicts the lactate levels measured in dialysate and 
blood. Dialysate levels increased in a similar way to plasma levels 
F I G U R E  1   A, A schematic representation of a cardiotochography (CTG) electrode modified to incorporate a needle-type microdialysis 
setup. The arrow denotes the positioning of the needle. B, A semi open needle (2), in which a microdialysis membrane is inserted (3), in which 
thin fused silica tubing is inserted (1). When dialysis fluid is pushed through the fused silica (4), the flow will leave the fused silica at the other 
end and be forced back (6), because the membrane is blocked by glue (7). While running back along the microdialysis membrane, exchange 
(5) of small molecules will occur between the dialysis fluid and the external fluid space. Fluid can be collected for analysis when leaving the 
dialysis membrane (8)
4  |     TIGCHELAAR ET AL.
upon de-oxygenation. When dialysate levels were corrected for 
in vitro recovery, plasma and dialysate levels were comparable 
(data not shown). Correlation of dialysate lactate levels with 
plasma lactate levels was 0.89, resulting in an R2 of .78 in the 
corresponding linear regression.
4  | DISCUSSION
In this study, we investigated whether microdialysis can be used to 
monitor subcutaneous lactate concentrations in the hypoxic rat. 
We were able to measure and compare the changes over time in 
F I G U R E  2   Oxygen saturation and blood lactate levels upon de-oxygenation for 60 min. Red lines depict saturation levels in 3 animals 
(percentage, right y-axis), green lines represent corresponding blood lactate levels (mmol/L, left y-axis). Red squares represent average 
oxygen saturation, green circles represent average blood lactate


































F I G U R E  3   Oxygenation, pCO2 and 
pH upon de-oxygenation for 60 min. 
Red lines depict saturation in 2 animals 
(percentage, right y-axis), blue lines depict 
corresponding pCO2 levels (mm Hg, 
right y-axis) and green lines represent 
corresponding pH values (left y-axis). Red 
squares depict average saturation, blue 
circles depict average pCO2 values and 
green diamonds depict average pH
































F I G U R E  4   Blood and dialysis 
lactate levels upon de-oxygenation for 
60 min. Red lines depict blood lactate 
levels in 3 animals, blue lines represent 
corresponding dialysis lactate levels 
(mmol/L). Red triangles depict average 
blood lactate, blue squares represent 
average lactate in dialysate
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subcutaneous and blood lactate levels. The observed agreement 
between both methods of lactate measurement supports further 
studies to determine the suitability of this method for clinical ap-
plications, for example, intrapartum human fetal monitoring.
We found an in vitro recovery of 24.7% for lactate in dialysate 
at a flow rate of 1.5 µL/min. This corresponds to values found for a 
flow rate of 1 µL/min in previous studies.16,17 A higher flow rate of 
5 µL resulted in a recovery of 8.9%. Although a lower flow rate im-
proves recovery, it increases the lag time between lactate measured 
in blood and dialysate.
Our results showed a good agreement between plasma and dial-
ysate lactate levels. Lactate levels from microdialysis followed blood 
lactate levels with a lag time of about 10 min, increasing and de-
creasing similarly over time, and showing comparable values after 
correction for recovery. This suggests that microdialysis in subcu-
taneous tissue can be used to monitor lactate as an alternative to 
blood analysis in the jugular vein.
Our microdialysis probe offers a new approach to continuous 
measurement of lactate and other compounds. Microdialysis as a 
sampling technique to measure the concentrations of different me-
tabolites in the interstitial fluid in the skin has been used for several 
purposes. In diabetes, in conjunction with a biosensor, it has been 
shown to be a reliable method to continuously measure glucose with 
high accuracy and very little discomfort for the patient.18,19
A study by Poscia et al20 showed that the glucose monitoring sys-
tem based on biosensor technology can be modified for continuous 
measurement of lactate in rabbits. Preliminary data suggest that this 
technique can be used for lactate measurement in humans for up 
to 16 h. Other studies show that microdialysis probes in the upper 
dermal tissue of the skin can measure lactate accurately, and that mi-
crodialysis lactate and glucose concentrations correspond to plasma 
concentrations.21,22
Clinical device requirements for a biosensor monitoring lac-
tate in human tissue are manifold. The materials used should be 
biocompatible. Any chemicals used for sensing must be affixed 
in a way that ensures that they do not separate from the sensor 
surface. Manufacturers will need to demonstrate that chemical 
leakage into surrounding tissue poses no health risk. Accuracy and 
stability of the sensor can be affected by bio-fouling, which can be 
caused by protein absorption, cellular adhesion, thrombus forma-
tion, and more.23 The microdialysis technique we used adheres to 
these qualifications.
Biosensors are designed to measure one specific compound. The 
microdialysis probe technology used in the present study allows the 
measurement of multiple compounds in the dialysate, such as glu-
cose, albumin, or inflammatory mediators.24 However, compounds 
can only be measured if their molecules can cross the microdialysis 
membrane. We used a membrane with pores of 18 kDa that small 
molecules (lactate: 90 Da) can easily pass through.
With the current design of our probe, placement of the probe 
is not more invasive than placement of a conventional CTG elec-
trode. The flow rate required for the measurement is very low and 
comparable to studies in other fields, for example, in a clinical study 
on neurosurgical patients by Hutchinson et al.25 As no transfer of 
fluid occurs with microdialysis due to tissue pressure, this method 
induces no tissue trauma during sampling. Additionally, in case of 
blockage of the outflow tract and leakage of the microdialysis mem-
brane, the cumulative amount of fluid perfused into the fetal scalp 
is very low (90 µL/h), and so not likely to harm the fetus or influence 
the birthing process in any way. In all, the current sampling tech-
nique would provide a safe and versatile method for monitoring the 
metabolic status of the fetus.
This is the first study investigating a novel application of microdi-
alysis for possible future use in the field of obstetrics. With the setup 
of this study, we were able to measure and compare the changes 
in lactate levels in subcutaneous tissue and in blood over time in 
hypoxic rats. The observed agreement between both methods of 
lactate measurement supports further studies to determine the suit-
ability of this method for several clinical applications.
Because it was a study in rats, we should be careful to general-
ize the results to human beings. Clinical studies in human settings 
are necessary to establish feasibility and validity. Lag time between 
lactate in serum and in subcutaneous tissue and stability of the mea-
surements are issues that we are addressing in ongoing studies.
5  | CONCLUSION
In this animal model, lactate levels in tissue fluid collected with mi-
crodialysis reflected blood lactate levels upon transient deprivation 
of oxygen. These results confirm that our microdialysis device is suit-
able for subcutaneous measurement of lactate. As the microdialysis 
probe technology allows measurement of multiple compounds in 
the dialysate, this technique may offer the unique possibility to shed 
light on fetal physiology during the intrapartum period.
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